Biologics Process Research & Development Co-op

Are you a passionate and curious scientist looking to make an impact in the world of biologics process research and development? Merck & Co. is seeking a highly motivated Co-op to join our team and make a difference.This is a great opportunity for someone eager to expand their knowledge and skills in the field. The successful candidate will have the opportunity to work on innovative projects and develop their technical expertise. In this role, you will support the development, optimization and scale-up of biologics manufacturing processes.To be successful in this role, you must have a strong chemistry or engineering background, excellent communication and problem-solving skills, and a deep interest in biologics process research and development. Knowledge of biopharmaceutical drug development, bioprocess engineering, and cell culture systems is also required. We’re looking for a creative individual with a passion for exploring novel ideas, and a commitment to producing high quality work. If this sounds like you, we want to hear from you!

According to JobzMall, the average salary range for a Biologics Process Research & Development Co-op in Boston, MA, USA is $44,903 - $89,807. This figure is based on the salaries submitted anonymously to JobzMall by employers and employees.

The salary range can vary depending on the experience, skills, and other factors of the individual.

Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company and one of the largest pharmaceutical companies in the world. Merck & Co., Inc. engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, Alliances and Healthcare Services. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures.